Conning Inc’s Verrica Pharmaceuticals VRCA Stock Holding History

Conning Inc’s Portfolio VRCA Stock Details VRCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-12,901	Closed	-$355K	–	379
2022 Q4	$355K	Buy	+12,901	New	+$344K	0.01%	274
2020 Q1	–	Sell	-12,901	Closed	-$2.05M	–	468
2019 Q4	$2.05M	Hold	12,901	–	–	0.07%	145
2019 Q3	$1.9M	Hold	12,901	–	–	0.07%	158
2019 Q2	$1.5M	Hold	12,901	–	–	0.05%	177
2019 Q1	$1.4M	Hold	12,901	–	–	0.04%	209
2018 Q4	$1.05M	Hold	12,901	–	–	0.04%	226
2018 Q3	$2.1M	Sell	12,901 -172	-1%	-$29.4K	0.06%	174
2018 Q2	$2.58M	Buy	+13,073	New	+$2.56M	0.08%	167

Other funds holding VRCA

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EAM Investors Solana Beach, California $1.12B AUM 390.6% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Conning Inc's VRCA Position: Q1 2023 in Review

Conning Inc sold out of Verrica Pharmaceuticals (VRCA) in Q1 2023, closing a stake of 12,901 shares — an estimated $355K sold.

Conning Inc first reported a position in VRCA in Q2 2018 and held it in 8 quarters. The position peaked at $2.58M in Q2 2018. 59 funds tracked by Wall St. Rank hold VRCA as of Q1 2023.

Conning Inc reported no remaining Verrica Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
Conning Inc sold 12,901 Verrica Pharmaceuticals shares in Q1 2023, an estimated $355K.
Conning Inc first reported a position in Verrica Pharmaceuticals in Q2 2018 and held it in 8 quarters.
Conning Inc's Verrica Pharmaceuticals position peaked at $2.58M in Q2 2018.
59 funds tracked by Wall St. Rank held Verrica Pharmaceuticals as of Q1 2023.

Based on Conning Inc's 13F filing for Q1 2023, filed 27 Apr 2023.